Company Directory / pharmaceuticals
PrivateFor profitpharmaceuticalsChina
SinoTau
SinoTau is a total solution provider specializing in generic drugs and innovative drugs.
- Founded
- 2005 21 years ago
- Staff
- 101-250 band, as listed
- Followers
- - on LinkedIn
- Funding
- $2.0B as listed, currency not stated
Set against six million companies
Size
101-250 people: larger than 85% of companies with a size listed
Age
21 years old.
Reach
Website ranked #8,869,000 in the world for traffic, about 455 visits a month.
What it does
BiotechnologyHealth CareLife SciencePharmaceuticalProduct Research
Funding, as listed
$2.0B currency not stated
- Rounds5
- LatestSeries e, Jul 2023
- Investors29, 3 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about SinoTau, field by field. Contact details are held but never shown.
The company
- Name
- SinoTau
- Type
- For profit
- Status
- Private
- Founded
- 2005
- Founders
- Xinsheng Xu
- Industry
- pharmaceuticals
- Categories
- Biotechnology, Health Care, Life Science, Pharmaceutical, Product Research
Where
- Country
- China
- Markets
- Asia-Pacific (APAC)
Size and reach
- Staff band
- 101-250
- Web traffic rank
- #8,869,000
- Monthly web visits
- 455
Funding, as listed
- Total
- 1,980,000,000 (currency not stated)
- Rounds
- 5
- Latest round
- Series e
- Latest round date
- Jul 2023
- Investors
- 29
- Lead investors
- 3
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
SinoTau may be growing as evidenced by the regulatory approval of their amyloid PET imaging radiopharmaceutical Neuraceq in China, which indicates a successful expansion of their product offerings in the pharmaceutical industry. Additionally, the collaboration with Blue Earth Diagnostics Ltd to bring a prostate cancer PET diagnostic imaging agent to China suggests an active strategy to diversify and enhance their diagnostic portfolio. These developments suggest that SinoTau is actively investing in new product launches and partnerships to expand its market presence in the health care and life science sectors.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
pharmaceuticals in China.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 38,667 companies in China and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.